刘露, 郑丹微, & 徐乐加. (2022). 加权TOPSIS法评价人血白蛋白治疗肝硬化的合理性. 中国药房, 33(23), 2917-2920. https://doi.org/10.6039/j.issn.1001-0408.2022.23.19
Chicago Style (17th ed.) Citation刘露, 郑丹微, and 徐乐加. "加权TOPSIS法评价人血白蛋白治疗肝硬化的合理性." 中国药房 33, no. 23 (2022): 2917-2920. https://doi.org/10.6039/j.issn.1001-0408.2022.23.19.
MLA (9th ed.) Citation刘露, et al. "加权TOPSIS法评价人血白蛋白治疗肝硬化的合理性." 中国药房, vol. 33, no. 23, 2022, pp. 2917-2920, https://doi.org/10.6039/j.issn.1001-0408.2022.23.19.
Warning: These citations may not always be 100% accurate.